Cochrane Abstracts
Risk‐reducing medications for primary breast cancer: a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risk‐reducing Medications for Primary Breast Cancer: a Network Meta‐analysis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Risk‐reducing_medications_for_primary_breast_cancer:_a_network_meta‐analysis. Accessed 24 September 2023.
Risk‐reducing medications for primary breast cancer: a network meta‐analysis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Risk‐reducing_medications_for_primary_breast_cancer:_a_network_meta‐analysis. Accessed September 24, 2023.
Risk‐reducing medications for primary breast cancer: a network meta‐analysis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Risk‐reducing_medications_for_primary_breast_cancer:_a_network_meta‐analysis
Risk‐reducing Medications for Primary Breast Cancer: a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. [cited 2023 September 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Risk‐reducing_medications_for_primary_breast_cancer:_a_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risk‐reducing medications for primary breast cancer: a network meta‐analysis
ID - 432430
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432430/all/Risk‐reducing_medications_for_primary_breast_cancer:_a_network_meta‐analysis
DB - Evidence Central
DP - Unbound Medicine
ER -
